Corrective and Preventive Actions (CAPA) In Pharmaceuticals
In pharmaceuticals research, production and marketing there may be errors from the human side or due to machine error. Despite […]
Access curated insights on pharmaceutical compliance, clinical regulations, drug safety, and industry practices. Trusted resources for pharma professionals worldwide.
In pharmaceuticals research, production and marketing there may be errors from the human side or due to machine error. Despite […]
Despite the considerable efforts invested by global regulatory authorities in evaluating the safety and efficacy of drugs for their citizens,
Pharmaceutical companies are innovative and generic drugs marketed in countries around the world. With limited market potential and varying products
Drugs are marketed only after their approval by regulatory authority. Only safe, effective and medicines of quality are approved by
A 21 CFR Part 11 compliance DMS is part of overall compliance and quality requirements across pharmaceutical organizations. Many tools
The critical information about the CMC (Chemistry, Manufacturing and Control) aspect of an active pharmaceutical ingredient or a finished pharmaceutical
Pharmaceuticals in Japan are regulated by the PMD Act, published by the PMDA and MHLW. These are the two main
Many regulatory delays in European Union happen not because of non-compliance, but because requirements are misunderstood early on. Different approval
The pharmaceutical market is growing with the rise in pharmaceutical innovations in Taiwan. The Taiwan Food and Drug Administration (TFDA) is